Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloid beta-Protein Precursor | 33 | 2023 | 1111 | 5.310 |
Why?
|
5' Untranslated Regions | 20 | 2020 | 256 | 3.550 |
Why?
|
Protein Biosynthesis | 25 | 2023 | 2113 | 2.860 |
Why?
|
Ferritins | 15 | 2020 | 598 | 2.130 |
Why?
|
Iron-Regulatory Proteins | 9 | 2020 | 30 | 1.990 |
Why?
|
Iron | 25 | 2023 | 1793 | 1.980 |
Why?
|
alpha-Synuclein | 8 | 2020 | 750 | 1.810 |
Why?
|
Alzheimer Disease | 36 | 2023 | 8599 | 1.660 |
Why?
|
Manganese Poisoning | 2 | 2019 | 13 | 1.300 |
Why?
|
Neurodegenerative Diseases | 6 | 2020 | 1087 | 0.940 |
Why?
|
Response Elements | 6 | 2019 | 309 | 0.940 |
Why?
|
RNA, Messenger | 29 | 2019 | 12795 | 0.940 |
Why?
|
Manganese | 2 | 2024 | 395 | 0.900 |
Why?
|
Interleukin-1 | 9 | 2008 | 1248 | 0.880 |
Why?
|
Neuroprotective Agents | 5 | 2024 | 957 | 0.840 |
Why?
|
Iron Regulatory Protein 1 | 4 | 2013 | 37 | 0.820 |
Why?
|
Amyloid beta-Peptides | 12 | 2023 | 3839 | 0.780 |
Why?
|
Neuroblastoma | 5 | 2024 | 1250 | 0.670 |
Why?
|
Parkinson Disease | 7 | 2020 | 2877 | 0.660 |
Why?
|
Lead Poisoning, Nervous System | 1 | 2019 | 12 | 0.660 |
Why?
|
Quinuclidines | 1 | 2019 | 24 | 0.650 |
Why?
|
Apoferritins | 1 | 2018 | 16 | 0.650 |
Why?
|
Muscarinic Agonists | 1 | 2019 | 91 | 0.630 |
Why?
|
Chelating Agents | 6 | 2010 | 387 | 0.590 |
Why?
|
S-Adenosylmethionine | 2 | 2019 | 218 | 0.570 |
Why?
|
Metals | 5 | 2010 | 719 | 0.560 |
Why?
|
Homeostasis | 5 | 2016 | 3323 | 0.510 |
Why?
|
Protein Synthesis Inhibitors | 3 | 2006 | 189 | 0.500 |
Why?
|
Deferoxamine | 5 | 2016 | 155 | 0.490 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 733 | 0.490 |
Why?
|
Thiophenes | 1 | 2019 | 569 | 0.470 |
Why?
|
Oxidative Stress | 4 | 2018 | 3113 | 0.470 |
Why?
|
Physostigmine | 3 | 2013 | 50 | 0.460 |
Why?
|
Drugs, Investigational | 2 | 2006 | 212 | 0.440 |
Why?
|
Neurons | 9 | 2020 | 9463 | 0.430 |
Why?
|
Paroxetine | 4 | 2006 | 182 | 0.410 |
Why?
|
Iron Chelating Agents | 3 | 2016 | 141 | 0.410 |
Why?
|
Neurotoxicity Syndromes | 1 | 2016 | 301 | 0.410 |
Why?
|
Transcription Factor AP-1 | 2 | 2016 | 321 | 0.390 |
Why?
|
Dicloxacillin | 1 | 2011 | 9 | 0.380 |
Why?
|
Strophanthidin | 1 | 2011 | 15 | 0.380 |
Why?
|
Cardenolides | 1 | 2011 | 17 | 0.380 |
Why?
|
Lead | 1 | 2016 | 879 | 0.360 |
Why?
|
Drug Evaluation, Preclinical | 5 | 2006 | 1334 | 0.340 |
Why?
|
Amyloid Precursor Protein Secretases | 4 | 2022 | 620 | 0.340 |
Why?
|
Alcoholism | 1 | 2020 | 1973 | 0.340 |
Why?
|
Erythromycin | 2 | 2006 | 115 | 0.330 |
Why?
|
Nucleic Acid Conformation | 4 | 2010 | 902 | 0.320 |
Why?
|
Neurofibrillary Tangles | 1 | 2011 | 457 | 0.310 |
Why?
|
Interleukin-1beta | 3 | 2016 | 999 | 0.310 |
Why?
|
Transfection | 10 | 2006 | 5774 | 0.300 |
Why?
|
Acetylcysteine | 2 | 2006 | 260 | 0.300 |
Why?
|
Cell Line, Tumor | 14 | 2024 | 16981 | 0.300 |
Why?
|
Gene Expression Regulation | 10 | 2020 | 11903 | 0.300 |
Why?
|
Cell Survival | 5 | 2024 | 5791 | 0.290 |
Why?
|
Brain | 13 | 2020 | 27112 | 0.290 |
Why?
|
I-kappa B Proteins | 1 | 2008 | 211 | 0.290 |
Why?
|
Dimercaprol | 2 | 2004 | 7 | 0.290 |
Why?
|
Interleukin-6 | 4 | 2016 | 3208 | 0.280 |
Why?
|
Ferric Compounds | 1 | 2009 | 378 | 0.280 |
Why?
|
Enzyme Activators | 1 | 2007 | 57 | 0.280 |
Why?
|
Iron-Sulfur Proteins | 5 | 2001 | 83 | 0.270 |
Why?
|
Untranslated Regions | 1 | 2006 | 29 | 0.270 |
Why?
|
Cholinesterase Inhibitors | 2 | 2004 | 242 | 0.260 |
Why?
|
Base Sequence | 14 | 2013 | 12441 | 0.260 |
Why?
|
Drug Design | 2 | 2010 | 1048 | 0.260 |
Why?
|
Lewy Bodies | 2 | 2020 | 145 | 0.250 |
Why?
|
ADAM Proteins | 1 | 2006 | 238 | 0.240 |
Why?
|
Siderophores | 1 | 2004 | 61 | 0.230 |
Why?
|
Genes, Reporter | 8 | 2013 | 1529 | 0.230 |
Why?
|
Animals | 41 | 2022 | 168459 | 0.230 |
Why?
|
Molecular Sequence Data | 12 | 2013 | 17635 | 0.220 |
Why?
|
Metals, Heavy | 1 | 2004 | 148 | 0.210 |
Why?
|
Tumor Cells, Cultured | 12 | 2006 | 6132 | 0.200 |
Why?
|
Mental Disorders | 2 | 2019 | 6845 | 0.190 |
Why?
|
Chloramphenicol O-Acetyltransferase | 4 | 2005 | 221 | 0.180 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2822 | 0.180 |
Why?
|
Signal Transduction | 9 | 2018 | 23445 | 0.180 |
Why?
|
Humans | 72 | 2024 | 761504 | 0.180 |
Why?
|
Drug Approval | 2 | 2005 | 814 | 0.180 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2013 | 790 | 0.180 |
Why?
|
Astrocytes | 2 | 2006 | 1346 | 0.180 |
Why?
|
Mice, Transgenic | 6 | 2020 | 9539 | 0.170 |
Why?
|
Mitragyna | 1 | 2019 | 16 | 0.170 |
Why?
|
RNA-Binding Proteins | 6 | 2001 | 1897 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2006 | 10766 | 0.170 |
Why?
|
Mice | 16 | 2022 | 81525 | 0.160 |
Why?
|
Protein Modification, Translational | 1 | 2018 | 21 | 0.160 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 2865 | 0.160 |
Why?
|
Rats | 10 | 2019 | 23742 | 0.150 |
Why?
|
Enhancer Elements, Genetic | 3 | 2005 | 1363 | 0.150 |
Why?
|
Down Syndrome | 2 | 2019 | 901 | 0.150 |
Why?
|
Luciferases | 3 | 2005 | 714 | 0.150 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1999 | 357 | 0.140 |
Why?
|
Cannabidiol | 1 | 2019 | 118 | 0.140 |
Why?
|
Copper | 1 | 2020 | 369 | 0.140 |
Why?
|
Lysosomes | 1 | 2023 | 924 | 0.140 |
Why?
|
Protein Binding | 8 | 2013 | 9351 | 0.140 |
Why?
|
Growth Hormone | 1 | 1999 | 569 | 0.140 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 2013 | 1058 | 0.130 |
Why?
|
Amyloid | 2 | 2016 | 841 | 0.130 |
Why?
|
Acute-Phase Reaction | 1 | 1996 | 91 | 0.130 |
Why?
|
Receptors, Transferrin | 3 | 2008 | 291 | 0.130 |
Why?
|
Cell Line | 6 | 2018 | 15601 | 0.130 |
Why?
|
Ghrelin | 1 | 2017 | 252 | 0.130 |
Why?
|
Inflammation Mediators | 1 | 2004 | 1886 | 0.130 |
Why?
|
Plaque, Amyloid | 3 | 2022 | 760 | 0.120 |
Why?
|
Methylation | 1 | 2018 | 1084 | 0.120 |
Why?
|
Ferrosoferric Oxide | 1 | 2016 | 348 | 0.120 |
Why?
|
Clioquinol | 2 | 2006 | 23 | 0.120 |
Why?
|
Protein Multimerization | 1 | 2020 | 983 | 0.120 |
Why?
|
MicroRNAs | 2 | 2022 | 3816 | 0.120 |
Why?
|
Blotting, Western | 2 | 2013 | 5035 | 0.120 |
Why?
|
Enterocytes | 1 | 2016 | 220 | 0.120 |
Why?
|
Triiodothyronine | 1 | 1996 | 493 | 0.120 |
Why?
|
Anti-Bacterial Agents | 2 | 2011 | 7407 | 0.110 |
Why?
|
Codon | 1 | 1996 | 601 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2002 | 1089 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3778 | 0.110 |
Why?
|
Iron Metabolism Disorders | 1 | 2014 | 24 | 0.110 |
Why?
|
NM23 Nucleoside Diphosphate Kinases | 1 | 2013 | 21 | 0.110 |
Why?
|
Hemopexin | 1 | 2013 | 33 | 0.110 |
Why?
|
Reactive Oxygen Species | 2 | 2018 | 2141 | 0.100 |
Why?
|
Gene Order | 1 | 2013 | 169 | 0.100 |
Why?
|
Memantine | 1 | 2012 | 108 | 0.100 |
Why?
|
Monoamine Oxidase | 1 | 2012 | 181 | 0.100 |
Why?
|
Dementia, Vascular | 1 | 2012 | 122 | 0.090 |
Why?
|
Cells, Cultured | 5 | 2013 | 18965 | 0.090 |
Why?
|
Autistic Disorder | 1 | 2020 | 1220 | 0.090 |
Why?
|
Environmental Pollutants | 1 | 2020 | 1277 | 0.090 |
Why?
|
Catecholamines | 1 | 2012 | 386 | 0.090 |
Why?
|
Protease Nexins | 1 | 2010 | 39 | 0.090 |
Why?
|
Ceruloplasmin | 1 | 2010 | 56 | 0.090 |
Why?
|
Chelation Therapy | 1 | 2010 | 77 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 2 | 2018 | 8181 | 0.090 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2016 | 441 | 0.090 |
Why?
|
Environmental Exposure | 2 | 2020 | 4486 | 0.090 |
Why?
|
Caco-2 Cells | 2 | 2008 | 364 | 0.080 |
Why?
|
Antioxidants | 2 | 2010 | 1668 | 0.080 |
Why?
|
Acute-Phase Proteins | 1 | 1990 | 250 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2006 | 7856 | 0.080 |
Why?
|
DNA | 6 | 2013 | 7212 | 0.080 |
Why?
|
Child Development | 1 | 2020 | 2306 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 2 | 2009 | 1974 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 4575 | 0.080 |
Why?
|
Levodopa | 1 | 2009 | 221 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7237 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2013 | 858 | 0.080 |
Why?
|
Cytokines | 1 | 2003 | 7396 | 0.070 |
Why?
|
Aniline Compounds | 1 | 2013 | 1069 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2010 | 5789 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 6 | 2005 | 2298 | 0.070 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 894 | 0.070 |
Why?
|
Enzyme Inhibitors | 2 | 2008 | 3712 | 0.070 |
Why?
|
Amyloid Neuropathies | 1 | 2006 | 15 | 0.070 |
Why?
|
Zinc | 1 | 2010 | 690 | 0.070 |
Why?
|
Nitric Oxide | 1 | 2015 | 2135 | 0.060 |
Why?
|
Poly C | 1 | 2005 | 6 | 0.060 |
Why?
|
Hydrolysis | 1 | 2007 | 664 | 0.060 |
Why?
|
Principal Component Analysis | 1 | 2008 | 943 | 0.060 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2006 | 311 | 0.060 |
Why?
|
Transcriptional Activation | 2 | 2018 | 1756 | 0.060 |
Why?
|
RNA, Double-Stranded | 1 | 2006 | 294 | 0.060 |
Why?
|
Consensus Sequence | 2 | 1996 | 365 | 0.060 |
Why?
|
Mutation | 2 | 2013 | 30052 | 0.060 |
Why?
|
Receptors, Glucagon | 1 | 2004 | 90 | 0.060 |
Why?
|
Drug Interactions | 2 | 2006 | 1416 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 22169 | 0.060 |
Why?
|
Synaptic Transmission | 1 | 2010 | 1173 | 0.060 |
Why?
|
Pregnancy Proteins | 1 | 2005 | 222 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3802 | 0.060 |
Why?
|
Peptide Fragments | 4 | 2006 | 5112 | 0.060 |
Why?
|
Apolipoproteins E | 1 | 2010 | 1444 | 0.060 |
Why?
|
Spectrometry, Fluorescence | 1 | 2006 | 685 | 0.060 |
Why?
|
Gene Expression | 2 | 2008 | 7581 | 0.060 |
Why?
|
Macaca mulatta | 1 | 2010 | 2329 | 0.060 |
Why?
|
Technology, Pharmaceutical | 1 | 2004 | 84 | 0.060 |
Why?
|
DNA Methylation | 1 | 2018 | 4398 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2005 | 413 | 0.050 |
Why?
|
Oxidation-Reduction | 2 | 2012 | 2231 | 0.050 |
Why?
|
Immunoprecipitation | 1 | 2005 | 878 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2004 | 344 | 0.050 |
Why?
|
Transgenes | 1 | 2006 | 1010 | 0.050 |
Why?
|
Ultraviolet Rays | 2 | 2005 | 1080 | 0.050 |
Why?
|
Pattern Recognition, Automated | 1 | 2008 | 997 | 0.050 |
Why?
|
HeLa Cells | 3 | 2018 | 3093 | 0.050 |
Why?
|
Pilot Projects | 2 | 2006 | 8631 | 0.050 |
Why?
|
Algorithms | 3 | 2013 | 14031 | 0.050 |
Why?
|
Protein Structure, Secondary | 1 | 2005 | 1229 | 0.050 |
Why?
|
Phosphorylation | 2 | 2016 | 8320 | 0.050 |
Why?
|
Immunoblotting | 1 | 2005 | 1646 | 0.050 |
Why?
|
Cloning, Molecular | 3 | 2003 | 4174 | 0.050 |
Why?
|
Iron-Binding Proteins | 1 | 2001 | 79 | 0.050 |
Why?
|
Up-Regulation | 3 | 2018 | 4124 | 0.050 |
Why?
|
Biotin | 1 | 2022 | 254 | 0.050 |
Why?
|
Azithromycin | 1 | 2003 | 199 | 0.050 |
Why?
|
Liver | 6 | 2005 | 7529 | 0.050 |
Why?
|
Plasmids | 2 | 2005 | 2269 | 0.050 |
Why?
|
RNA | 2 | 2009 | 2726 | 0.050 |
Why?
|
Pheochromocytoma | 1 | 2003 | 328 | 0.050 |
Why?
|
Models, Biological | 2 | 2008 | 9469 | 0.050 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 2000 | 139 | 0.050 |
Why?
|
Cytoplasm | 1 | 2005 | 1510 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2006 | 3597 | 0.040 |
Why?
|
Organometallic Compounds | 1 | 2004 | 647 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2005 | 6534 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2455 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1999 | 1741 | 0.040 |
Why?
|
Cluster Analysis | 3 | 2013 | 2707 | 0.040 |
Why?
|
Melatonin | 1 | 2004 | 669 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2010 | 2180 | 0.040 |
Why?
|
Cation Transport Proteins | 1 | 2001 | 327 | 0.040 |
Why?
|
Magnesium | 1 | 2002 | 804 | 0.040 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1999 | 176 | 0.040 |
Why?
|
Presenilin-1 | 1 | 2022 | 660 | 0.040 |
Why?
|
Astrocytoma | 1 | 2003 | 775 | 0.040 |
Why?
|
Thalidomide | 1 | 2004 | 885 | 0.040 |
Why?
|
Amino Acid Sequence | 5 | 2010 | 13446 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3792 | 0.040 |
Why?
|
tau Proteins | 1 | 2008 | 2095 | 0.040 |
Why?
|
Pituitary Gland | 1 | 2000 | 635 | 0.040 |
Why?
|
Amyloidosis | 1 | 2004 | 817 | 0.040 |
Why?
|
Computational Biology | 1 | 2010 | 3518 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2000 | 701 | 0.040 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2003 | 732 | 0.040 |
Why?
|
RNA Precursors | 1 | 2018 | 212 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2010 | 9420 | 0.030 |
Why?
|
Hair | 1 | 2020 | 498 | 0.030 |
Why?
|
Cross Reactions | 1 | 1999 | 817 | 0.030 |
Why?
|
Antibody Specificity | 1 | 1999 | 1060 | 0.030 |
Why?
|
Liver Neoplasms | 4 | 1999 | 4320 | 0.030 |
Why?
|
Down-Regulation | 1 | 2004 | 2919 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2016 | 73 | 0.030 |
Why?
|
Protein Kinase C | 1 | 2000 | 1202 | 0.030 |
Why?
|
Models, Molecular | 1 | 2006 | 5439 | 0.030 |
Why?
|
Holography | 1 | 2016 | 80 | 0.030 |
Why?
|
Receptors, Thyroid Hormone | 1 | 1996 | 199 | 0.030 |
Why?
|
Intelligence | 1 | 2020 | 924 | 0.030 |
Why?
|
MPTP Poisoning | 1 | 2015 | 37 | 0.030 |
Why?
|
Inflammation | 3 | 2013 | 10773 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2004 | 2917 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2016 | 453 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2122 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3305 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2016 | 794 | 0.030 |
Why?
|
Apoproteins | 1 | 2013 | 45 | 0.030 |
Why?
|
Substantia Nigra | 1 | 2015 | 350 | 0.030 |
Why?
|
Poly A | 1 | 1993 | 181 | 0.030 |
Why?
|
Serum Amyloid A Protein | 1 | 1993 | 127 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2004 | 2226 | 0.030 |
Why?
|
Peroxides | 1 | 2013 | 74 | 0.030 |
Why?
|
PC12 Cells | 1 | 2013 | 317 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 687 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2013 | 452 | 0.030 |
Why?
|
Transcription Factors | 2 | 2016 | 12128 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 3617 | 0.030 |
Why?
|
Rabbits | 1 | 1999 | 4772 | 0.030 |
Why?
|
Receptors, Muscarinic | 1 | 2013 | 157 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2004 | 4352 | 0.030 |
Why?
|
Epitopes | 1 | 1999 | 2503 | 0.030 |
Why?
|
Biological Transport | 2 | 2001 | 2091 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2013 | 614 | 0.020 |
Why?
|
Species Specificity | 1 | 1996 | 2414 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2004 | 3673 | 0.020 |
Why?
|
Ascorbic Acid | 1 | 1995 | 655 | 0.020 |
Why?
|
Iron Regulatory Protein 2 | 2 | 2001 | 42 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 2 | 1990 | 1302 | 0.020 |
Why?
|
Heme | 1 | 2013 | 313 | 0.020 |
Why?
|
Fasting | 1 | 2017 | 1603 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4174 | 0.020 |
Why?
|
Polyribosomes | 1 | 1990 | 109 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2626 | 0.020 |
Why?
|
Glioblastoma | 1 | 2006 | 3482 | 0.020 |
Why?
|
Heme Oxygenase-1 | 1 | 2013 | 366 | 0.020 |
Why?
|
Blotting, Southwestern | 1 | 2010 | 2 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15936 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2013 | 1163 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 495 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2010 | 293 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4278 | 0.020 |
Why?
|
Calcium | 1 | 2002 | 5722 | 0.020 |
Why?
|
Swine | 1 | 1999 | 5915 | 0.020 |
Why?
|
Endocytosis | 1 | 2013 | 957 | 0.020 |
Why?
|
Protein Conformation | 1 | 1996 | 3968 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1541 | 0.020 |
Why?
|
Organ Specificity | 1 | 2013 | 1967 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2008 | 369 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 1990 | 1434 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 1990 | 750 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1996 | 3734 | 0.020 |
Why?
|
Oxygen | 1 | 1999 | 4227 | 0.020 |
Why?
|
NF-kappa B | 1 | 2016 | 2490 | 0.020 |
Why?
|
YY1 Transcription Factor | 1 | 2006 | 60 | 0.020 |
Why?
|
Intestines | 1 | 2016 | 1909 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2012 | 1675 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8708 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2819 | 0.020 |
Why?
|
Glucose | 1 | 2017 | 4346 | 0.020 |
Why?
|
Tumor Necrosis Factor Decoy Receptors | 1 | 2004 | 8 | 0.020 |
Why?
|
Brain Neoplasms | 2 | 2004 | 9031 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6990 | 0.020 |
Why?
|
Dopamine | 1 | 2012 | 1607 | 0.010 |
Why?
|
Apolipoproteins C | 1 | 1984 | 59 | 0.010 |
Why?
|
Trace Elements | 1 | 2006 | 195 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 502 | 0.010 |
Why?
|
Binding Sites | 1 | 2013 | 6055 | 0.010 |
Why?
|
Lymphocytes | 1 | 2012 | 2612 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 39967 | 0.010 |
Why?
|
United States | 2 | 2019 | 72334 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1999 | 9177 | 0.010 |
Why?
|
Apolipoproteins | 1 | 1984 | 326 | 0.010 |
Why?
|
Cations, Divalent | 1 | 2001 | 168 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 2013 | 2656 | 0.010 |
Why?
|
Fibroblasts | 1 | 2012 | 4141 | 0.010 |
Why?
|
Cell Death | 1 | 2006 | 1678 | 0.010 |
Why?
|
Brain Injuries | 1 | 2013 | 2053 | 0.010 |
Why?
|
Brain Chemistry | 1 | 2004 | 960 | 0.010 |
Why?
|
Ribonuclease T1 | 1 | 1999 | 3 | 0.010 |
Why?
|
Heart Rate | 1 | 2012 | 4195 | 0.010 |
Why?
|
Genome, Human | 1 | 2013 | 4425 | 0.010 |
Why?
|
Neoplasms | 1 | 2008 | 22170 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2000 | 817 | 0.010 |
Why?
|
3' Untranslated Regions | 1 | 2001 | 519 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22176 | 0.010 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2000 | 329 | 0.010 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2001 | 416 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1999 | 687 | 0.010 |
Why?
|
Models, Neurological | 1 | 2004 | 1767 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14414 | 0.010 |
Why?
|
Female | 4 | 2020 | 392644 | 0.010 |
Why?
|
Blood Pressure | 1 | 2012 | 8481 | 0.010 |
Why?
|
Thyrotropin | 1 | 1999 | 834 | 0.010 |
Why?
|
Surface Properties | 1 | 1999 | 1161 | 0.010 |
Why?
|
Models, Genetic | 1 | 2006 | 3442 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1246 | 0.010 |
Why?
|
Genotype | 1 | 2010 | 12990 | 0.010 |
Why?
|
Protein Isoforms | 1 | 1999 | 1699 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2006 | 4414 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2000 | 1486 | 0.010 |
Why?
|
Dactinomycin | 1 | 1993 | 304 | 0.010 |
Why?
|
Drug Stability | 1 | 1993 | 291 | 0.010 |
Why?
|
Heparin | 1 | 1999 | 1634 | 0.010 |
Why?
|
Child | 1 | 2020 | 80153 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2006 | 5796 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1993 | 522 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2004 | 3415 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1993 | 1545 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11076 | 0.010 |
Why?
|
Aged | 2 | 2017 | 169289 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 17904 | 0.000 |
Why?
|
Male | 2 | 2017 | 360804 | 0.000 |
Why?
|
Leukemia | 1 | 1995 | 1522 | 0.000 |
Why?
|
Kinetics | 1 | 1993 | 6374 | 0.000 |
Why?
|
Apolipoprotein C-II | 1 | 1984 | 15 | 0.000 |
Why?
|
Mitochondria, Liver | 1 | 1985 | 190 | 0.000 |
Why?
|
alpha 1-Antitrypsin | 1 | 1985 | 167 | 0.000 |
Why?
|
RNA, Ribosomal | 1 | 1985 | 227 | 0.000 |
Why?
|
Genes | 1 | 1988 | 1823 | 0.000 |
Why?
|
Monocytes | 1 | 1993 | 2570 | 0.000 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1999 | 8547 | 0.000 |
Why?
|
Middle Aged | 1 | 2017 | 220895 | 0.000 |
Why?
|
Albumins | 1 | 1985 | 575 | 0.000 |
Why?
|
Risk Factors | 1 | 2006 | 74206 | 0.000 |
Why?
|
Intestinal Mucosa | 1 | 1984 | 3032 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1999 | 21012 | 0.000 |
Why?
|